The DOI matches its Crossref record.
VARIABLE ORAL ABSORPTION OF CYCLOSPORINE: A Biopharmaceutical Risk Factor for Chronic Renal Allograft Rejection1,2
Abstract
The inter- and intrapatient variability in cyclosporine (CsA) pharmacokinetics obfuscates the relationship between therapeutic outcome and administered dose, thereby impeding the development of secure algorithms for CsA therapy. In an attempt to understand these variabilities, we previously performed serial pharmacokinetic profiles on 160 renal transplant recipients during the first 3 posttransplant months. Drug exposure was estimated by the average CsA concentration (Cav), which was defined as a time-corrected (tau, hours) expression of the area under the concentration-time curve (AUC), i.e., Cav = (AUC/tau). Low Cav values correlated with an increased occurrence of acute rejection episodes and 1-year rate of renal transplant loss. The present study examines the results of serial pharmacokinetic profiling of a cohort of 204 patients treated for up to 5 years with CsA doses selected to achieve target Cav values. Multivariate analyses correlated demographic factors, laboratory values, clinical parameters, and CsA pharmacokinetic parameters with the occurrence of chronic rejection. The factors that predisposed to chronic rejection included a previous acute rejection episode, initial acute tubular necrosis, diastolic blood pressure above 85 mmHg, and African-American race. Once regression models were adjusted to account for the impact of these factors, we examined the association between the incidence of chronic rejection and individual pharmacokinetic parameters, including the mean values of the absolute and dose-corrected trough, peak, and Cav concentrations, as well as the percent coefficient of variation of each of these values. Receiver operating characteristic curves documented that 27% of the total risk for the occurrence of chronic rejection was attributable to a greater than 20% coefficient of variation of the dose-corrected Cav, namely, AUC/(tau.mg). This study suggests that variable oral bioavailability of CsA represents a biopharmaceutical risk factor for the occurrence of chronic rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Denhaerynck, K., Dobbels, F., Cleemput, I., Desmyttere, A., Schafer-Keller, P., Schaub, S., & De Geest, S. (2005) · Transplant International · doi:10.1111/j.1432-2277.2005.00176.x · Cited by 424
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
Christians, U., Jacobsen, W., Benet, L. Z., & Lampen, A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00003 · Cited by 323
THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1
Halloran, P. F., Helms, L. M. H., Kung, L., & Noujaim, J. (1999) · Transplantation · doi:10.1097/00007890-199911150-00023 · Cited by 317
Therapeutic drug monitoring of immunosuppressant drugs in clinical practice
Kahan, B. D., Keown, P., Levy, G. A., & Johnston, A. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85038-x · Cited by 292
Self-citationKahan, B. D., Podbielski, J., Napoli, K. L., Katz, S. M., Meier-Kriesche, H.-U., & Van Buren, C. T. (1998) · Transplantation · doi:10.1097/00007890-199810270-00013 · Cited by 288
Self-citation
Metadata
- Authors
- Kahan, B. D., Welsh, M., Schoenberg, L., Rutzky, L. P., Katz, S. M., Urbauer, D. L., & Van Buren, C. T.
- Venue
- Transplantation
- Published
- 1996-09
- Volume
- 62
- Issue
- 5
- Pages
- 599-606
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2041951312
- Cited by
- 249
- References
- 0
- FWCI
- 21.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: VARIABLE ORAL ABSORPTION OF CYCLOSPORINE: A Biopharmaceutical Risk Factor for Chronic Renal Allograft Rejection1,2. https://app.cochat.ai/papers/10.1097/00007890-199609150-00010
- The paper
- Kahan, B. D., Welsh, M., Schoenberg, L., Rutzky, L. P., Katz, S. M., Urbauer, D. L., & Van Buren, C. T. (1996). VARIABLE ORAL ABSORPTION OF CYCLOSPORINE: A Biopharmaceutical Risk Factor for Chronic Renal Allograft Rejection1,2. Transplantation. https://doi.org/10.1097/00007890-199609150-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.